Abu Rached N, Ruth J, Gambichler T, Ocker L, Bechara F
Ann Med. 2024; 56(1):2382372.
PMID: 39046819
PMC: 11271124.
DOI: 10.1080/07853890.2024.2382372.
Syed R, Alshammari M, Banu H, Khojali W, Jafar M, Nagaraju P
Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(10):7421-7437.
PMID: 38761210
DOI: 10.1007/s00210-024-03153-0.
Zheng B, Jiang X, Liu Y, Cheng F, Zhang Y, Niu C
Discov Oncol. 2024; 15(1):156.
PMID: 38733531
PMC: 11088579.
DOI: 10.1007/s12672-024-01018-9.
Mourkioti I, Angelopoulou A, Belogiannis K, Lagopati N, Potamianos S, Kyrodimos E
Cells. 2022; 11(15).
PMID: 35954292
PMC: 9367915.
DOI: 10.3390/cells11152449.
Liu T, Wang J, Sun L, Li M, He X, Jiang J
Cell Cycle. 2021; 20(16):1603-1616.
PMID: 34313525
PMC: 8409782.
DOI: 10.1080/15384101.2021.1956090.
The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma.
Saito N, Hirai N, Aoki K, Suzuki R, Fujita S, Nakayama H
Cancers (Basel). 2019; 11(1).
PMID: 30669546
PMC: 6356490.
DOI: 10.3390/cancers11010121.
NUMB and NUMBL differences in gene regulation.
Garcia-Heredia J, Carnero A
Oncotarget. 2018; 9(10):9219-9234.
PMID: 29507685
PMC: 5823667.
DOI: 10.18632/oncotarget.24186.
Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR-424-3p and targeting PTEN/PI3K/Akt pathway.
Lu C, Wang H, Chen S, Yang R, Li H, Zhang G
J Cell Mol Med. 2018; 22(4):2478-2487.
PMID: 29392841
PMC: 5867147.
DOI: 10.1111/jcmm.13556.
Phosphatase and tensin homolog (PTEN) is down-regulated in human NK/T-cell lymphoma and corrects with clinical outcomes.
Fu X, Zhang X, Gao J, Li X, Zhang L, Li L
Medicine (Baltimore). 2017; 96(29):e7111.
PMID: 28723738
PMC: 5521878.
DOI: 10.1097/MD.0000000000007111.
Regulation of PTEN degradation and NEDD4-1 E3 ligase activity by Numb.
Shao C, Li Z, Ahmad N, Liu X
Cell Cycle. 2017; 16(10):957-967.
PMID: 28437168
PMC: 5462079.
DOI: 10.1080/15384101.2017.1310351.
The Y-located proto-oncogene TSPY exacerbates and its X-homologue TSPX inhibits transactivation functions of androgen receptor and its constitutively active variants.
Li Y, Zhang D, Qiu Y, Kido T, Lau Y
Hum Mol Genet. 2017; 26(5):901-912.
PMID: 28169398
PMC: 6075507.
DOI: 10.1093/hmg/ddx005.
The role of GATA2 in lethal prostate cancer aggressiveness.
Rodriguez-Bravo V, Carceles-Cordon M, Hoshida Y, Cordon-Cardo C, Galsky M, Domingo-Domenech J
Nat Rev Urol. 2016; 14(1):38-48.
PMID: 27872477
PMC: 5489122.
DOI: 10.1038/nrurol.2016.225.
MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer.
Wu Y, Qi H, Deng D, Luo Y, Yang S
Tumour Biol. 2016; 37(9):12061-12070.
PMID: 27188433
DOI: 10.1007/s13277-016-5074-2.
Palmitoylated claudin7 captured in glycolipid-enriched membrane microdomains promotes metastasis via associated transmembrane and cytosolic molecules.
Thuma F, Heiler S, Schnolzer M, Zoller M
Oncotarget. 2016; 7(21):30659-77.
PMID: 27120791
PMC: 5058708.
DOI: 10.18632/oncotarget.8928.
The therapeutic potential of mTOR inhibitors in breast cancer.
Steelman L, Martelli A, Cocco L, Libra M, Nicoletti F, Abrams S
Br J Clin Pharmacol. 2016; 82(5):1189-1212.
PMID: 27059645
PMC: 5061784.
DOI: 10.1111/bcp.12958.
Notch signaling in prostate cancer: refining a therapeutic opportunity.
Su Q, Xin L
Histol Histopathol. 2015; 31(2):149-57.
PMID: 26521657
PMC: 4822406.
DOI: 10.14670/HH-11-685.
PTEN mediates Notch-dependent stalk cell arrest in angiogenesis.
Serra H, Chivite I, Angulo-Urarte A, Soler A, Sutherland J, Arruabarrena-Aristorena A
Nat Commun. 2015; 6:7935.
PMID: 26228240
PMC: 5426521.
DOI: 10.1038/ncomms8935.
